Publications by authors named "Charles Gregory"

Claim this Profile
M
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C.
Vera Binder, Wantong Li, Muhammad Faisal, Konur Oyman, Donn L Calkins, T Charles Gregory

Cell Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.
Steven Sher, Ethan Whipp, Janek Walker, Pu Zhang, Larry Beaver, Charles Gregory

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.
Zachary A Hing, Janek S Walker, Ethan C Whipp, Lindsey Brinton, Matthew Cannon, Charles T Gregory

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.
Janek S Walker, Zachary A Hing, Steven Sher, James Cronin, Katie Williams, Charles T Gregory

Nat Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wellens' Syndrome in the Setting of the 2019 Novel Coronavirus (COVID-19).
Karim O Elkholy, Elidona Mirashi, Yury Malyshev, Gregory Charles, Sonu Sahni

Cureus· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Caner Saygin, Karilyn Larkin, James S Blachly, Shelley Orwick, Apollinaire Ngankeu, Charles T Gregory

Am J Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease.
Matthew Cannon, Hannah Phillips, Sidney Smith, Katie Williams, Lindsey Brinton, Charles Gregory

J Clin Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon Barcodes.
Emily M Teets, Charles Gregory, Jami Shaffer, James S Blachly, Bradley W Blaser

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation.
Kyong-Rim Kieffer-Kwon, Keisuke Nimura, Suhas S P Rao, Jianliang Xu, Seolkyoung Jung, Charles Gregory

Mol Cell· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors.
Antoinette R Tan, Darlene G Gibbon, Mark N Stein, Diana Lindquist, Jeffery W Edenfield, Charles Gregory

Cancer Chemother Pharmacol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors.
Joe J Stephenson, Charles Gregory, Howard Burris, Tim Larson, Udit Verma

Clin Colorectal Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis